A Phase I Study of Triapine (R) in Combination With Doxorubicin in Refractory Tumors
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Doxorubicin (Primary) ; OCX 191 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 24 Aug 2008 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
- 24 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2005 New trial record.